ACS patients - Globe Thesis

Keyword [ACS patients] Result: 21 - 40 \| Page: 2 of 5
21.	The Change Of CTnI And NT-proBNP For ACS Patients After PCI And Its Predictive Value Of MACE
22.	Differences Of IMR Between The Stable Angina And ACS Patients Undergoing PCI And Its Meaning
23.	A Comparison Study On ACS Patients Between The Evaluation Of Treatment Sensitivity Of Clopidogrel And Genetic Polymorphism
24.	ACS Patients With Delayed Decision-making Factors And Correlation Between Family Functioning And Level Of Hope
25.	Application Of The Thrombelastography As A Guidance To Antiplatelet Therapy For ACS Patients Duringthe Perioperative Period Of PCI
26.	The Relationship Of ACS Patients Complicated With Diabetes With Carotid Artery IMT, IL-18,MMP-9 And Fib
27.	Impacts Of Renal Function And Fibrinogen On Platelet Reactivity And Outcomes Of ACS Patients Receiving Clopidogrel And Undergoing PCI
28.	Correlation Between Ejection Fraction And TCM Syndrome Types In ACS Patients After PCI And Effects Of Traditional Chinese Medicine
29.	The Study Of Clinical Characteristics Of Acs Patients And "Toxin" And Related Pathogenesis
30.	Contemporary Clinical Application And Individualized Anti-platelet Treatment With Ticagrelor In ACS Patients
31.	The Impact Of High Platelet Reactivity(HPR) On Clinical Outcomes For ACS Patients With DM And Calcification After PCI
32.	The Effects Of Different Dose Of Atorvastatin On Serum Oxidized Low-Density Lipoprotein In ACS Patients
33.	The Effects Of Burnout On The Levels Of Cortisol In ACS Patients And The Effects Of Cortisol Levels On Prognosis In Patients With ACS
34.	Study On The Content And Significance Of MMP-9 And MMP-9/TIMP-1 In Serum Of ACS Patients
35.	Clinical Application Of Different Doses Of Bivalirudin In NSTE-ACS Patients
36.	Research On Anti-platelet Drugs In ACS Patients With CYP2C19 Intermediate Metabolizer Receiving PCI And The Underlying Mechanisms
37.	The Analysis Of Polypharmacy Status And Adverse Reactions Of Statins With Different Metabolic Characteristics In Elderly ACS Patients
38.	Relationship Between TG / HDL-C Level And In-Stent Restenosis After PCI In ACS Patients
39.	The Clinical Outcome In ACS Patients With IABP And Different SYNTAX Score
40.	Clinical Significance Of Serum Cystatin C In ACS Patients With Metabolic Syndrome
<<First <Prev Next> Last>> Jump to